Market Overview:
The global dry eye syndrome treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of dry eye syndrome, rising awareness about available treatments, and growing demand for ophthalmic devices. Based on type, the global dry eye syndrome treatment market is segmented into liquid drops, gel, liquid wipes, eye ointment, and other segments. The liquid drops segment is expected to dominate the market during the forecast period owing to its high usage rates and widespread availability. Based on application, the global dry eye syndrome treatment market is segmented into hospital care settings, clinic care settings, and home care settings. The hospital care setting segment dominates the overall application landscape due to increased incidence of dry eyes in hospitalized patients across different geographies.
Product Definition:
Dry Eye Syndrome Treatment is the use of artificial tears, lacrimal plugs, and other therapies to treat the symptoms of dry eye syndrome. The importance of Dry Eye Syndrome Treatment is that it can help relieve the symptoms of dry eye syndrome, which can include irritation, pain, blurred vision, and a feeling of grittiness or sand in the eyes.
Liquid Drops:
Liquid drops are used for the treatment of dry eye syndrome. It is a solution of artificial tears that help in lubricating eyes, which are not able to produce enough tear fluid due to certain conditions such as Meibomian gland dysfunction (MGD) or Sjogren's syndrome. The product also helps in reducing inflammation and irritation caused by dry eye symptoms such as itchy eyes, burning sensation, light sensitivity and redness of eyes along with reduced tearing.
Gel:
Gel is a prescription eye drop used to treat dry eyes. It works by restoring the moisture content in the eyes. The treatment is effective and safe for all age groups, races, and both men & women. Gel comes in different forms such as solutions or suspensions depending on the concentration of solution required for treating dry eye symptoms such as burning sensation, itchy eyes or blurred vision among others.
Application Insights:
Based on application, the global market is segmented into hospital, clinic and home care. The hospital segment dominated the overall industry in terms of revenue in 2017. Dry eye syndrome often requires medical attention at a hospital due to its acute nature as well as because of the complexity involved in diagnosing and treating this condition. In addition, dry eye syndrome may also be diagnosed at a clinic or doctor's office during routine check-ups or examinations. Thus, it can be said that clinics are likely to remain one of the prominent end-use markets for dry eye treatment products over the forecast period owing to their accessibility and ease of use compared with hospitals.
The home care application is anticipated to witness significant growth over next six years owing to increasing awareness about early diagnosis & treatment methods for DRY EYE SYNDROME among individuals affected by this condition & growing preference towards self-medication among patients suffering from Drys Eye Syndrome (DYS).
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large patient pool and well-established healthcare infrastructure. Moreover, an increase in dry eye syndrome research activities by major universities and institutes is expected to fuel the regional growth over the forecast period. For instance, according to Dry Eye Research Foundation (DFRF), there are more than 100 DFRF scientists currently investigating dry eye disease at various universities across U.S.
Asia Pacific is anticipated to witness lucrative growth over the next eight years due to factors such as increasing geriatric population prone to ophthalmic disorders coupled with rising disposable income leading towards increased demand for advanced treatment options for dry eye syndrome patients.
Major players operating in this industry include Bausch & Lomb; Cipla Inc.; Dr Reddy's Laboratories Ltd.
Growth Factors:
- Increasing prevalence of dry eye syndrome (DES) due to changing lifestyles and environmental factors.
- Growing awareness about the symptoms and treatment options for DES among patients and healthcare professionals.
- Rising demand for novel therapies for the treatment of DES.
- increasing R&D investments by pharmaceutical companies in dry eye syndrome therapeutics market .
Scope Of The Report
Report Attributes
Report Details
Report Title
Dry Eye Syndrome Treatment Market Research Report
By Type
Liquid Drops, Gel, Liquid Wipes, Eye Ointment, Other
By Application
Hospital, Clinic, Home Care
By Companies
Novartis, Allergan, Otsuka, Santen Pharmaceutical, Nicox, Auven Therapeutics, Akorn, Bausch & Lomb, Alimera, GlaxoSmithKline, Novartis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
194
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Dry Eye Syndrome Treatment Market Report Segments:
The global Dry Eye Syndrome Treatment market is segmented on the basis of:
Types
Liquid Drops, Gel, Liquid Wipes, Eye Ointment, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Home Care
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Allergan
- Otsuka
- Santen Pharmaceutical
- Nicox
- Auven Therapeutics
- Akorn
- Bausch & Lomb
- Alimera
- GlaxoSmithKline
- Novartis
Highlights of The Dry Eye Syndrome Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Liquid Drops
- Gel
- Liquid Wipes
- Eye Ointment
- Other
- By Application:
- Hospital
- Clinic
- Home Care
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Dry Eye Syndrome Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best treatment for dry eye syndrome will vary depending on the individual's symptoms and medical history. However, some common treatments for dry eye syndrome include over-the-counter eyewash products and prescription medications such as artificial tears or ointments.
Some of the major players in the dry eye syndrome treatment market are Novartis, Allergan, Otsuka, Santen Pharmaceutical, Nicox, Auven Therapeutics, Akorn, Bausch & Lomb, Alimera, GlaxoSmithKline, Novartis.
The dry eye syndrome treatment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Dry Eye Syndrome Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Dry Eye Syndrome Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Dry Eye Syndrome Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Dry Eye Syndrome Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Dry Eye Syndrome Treatment Market Size & Forecast, 2020-2028
4.5.1 Dry Eye Syndrome Treatment Market Size and Y-o-Y Growth
4.5.2 Dry Eye Syndrome Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Liquid Drops
5.2.2 Gel
5.2.3 Liquid Wipes
5.2.4 Eye Ointment
5.2.5 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Home Care
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Dry Eye Syndrome Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Dry Eye Syndrome Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Liquid Drops
9.6.2 Gel
9.6.3 Liquid Wipes
9.6.4 Eye Ointment
9.6.5 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Home Care
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Liquid Drops
10.6.2 Gel
10.6.3 Liquid Wipes
10.6.4 Eye Ointment
10.6.5 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Home Care
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Liquid Drops
11.6.2 Gel
11.6.3 Liquid Wipes
11.6.4 Eye Ointment
11.6.5 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Home Care
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Liquid Drops
12.6.2 Gel
12.6.3 Liquid Wipes
12.6.4 Eye Ointment
12.6.5 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Home Care
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Liquid Drops
13.6.2 Gel
13.6.3 Liquid Wipes
13.6.4 Eye Ointment
13.6.5 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Home Care
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Dry Eye Syndrome Treatment Market: Competitive Dashboard
14.2 Global Dry Eye Syndrome Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Allergan
14.3.3 Otsuka
14.3.4 Santen Pharmaceutical
14.3.5 Nicox
14.3.6 Auven Therapeutics
14.3.7 Akorn
14.3.8 Bausch & Lomb
14.3.9 Alimera
14.3.10 GlaxoSmithKline
14.3.11 Novartis
